Riluzole is indicated for the treatment of amyotrophic lateral sclerosis.
Sunovion Pharmaceuticals Inc is the owner of the Eszopiclone drug.
Glenmark Generics Inc USA, the subsidiary of Glenmark Generics Ltd has received nod for it's Hydrocortisone Butyrate Cream USP (0.1 per cent), abbreviated new drug approval from the United States Food and Drug Administration, Glenmark Pharmaceuticals said in a statement.